Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
NCT01442779Phase 2Completed
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Sep 2000
- Primary completion
- May 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in idiopathic pulmonary fibrosis (IPF), sponsored by Texas Tech University Health Sciences Center. Started Sep 2000; status: completed.
02
Drugs
interferon alfa
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT01442779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442779.